Literature DB >> 11432665

Primary gastrointestinal B-cell lymphoma. A clincopathological and immunohistochemical study of 61 cases with an evaluation of prognostic parameters.

J Krugmann1, S Dirnhofer, A Gschwendtner, U Berresheim, R Greil, K Krugmann, F Fend.   

Abstract

We hereby present a retrospective clinicopathological and immunohistochemical study of surgically resected primary gastrointestinal (GI) lymphoma with an analysis of parameters of potential prognostic relevance. From a larger series of 144 cases of primary GI lymphomas, we chose 61 cases with sufficient clinical follow-up (mean 60, range 1-219 months), classified either as extranodal marginal zone B-cell lymphoma of MALT type (MALT lymphoma) or diffuse large B-cell lymphoma (DLBCL), after having excluded other subtypes. In addition to conventional clinical and morphological parameters, the expression levels of Ki-67 (MIB-1), bcl-2 and p53 were evaluated for prognostic significance. Twenty-one (34.4%) cases were classified as pure low grade marginal zone B-cell lymphoma of MALT type, 12 (19.7%) cases as low grade MALT lymphoma with a high grade component (mixed type), and 28 (45.9%) cases as primary extranodal DLBCL. Most of the lymphomas (53/61; 86.9%) were localized in the stomach, 3 (4.9%) in the small bowel, 3 (4.9%) multifocal in both stomach and small intestine and 2 (3.3%) in the large bowel. MIB-1 expression in more than 30% of tumor cells was detected in 42 (68.6%), bcl-2 expression in 20 (32.8%) and p53 accumulation in more than 10% of neoplastic cells in 16 (26.2%) lymphomas. Both high Ki-67 expression and p53 accumulation were more prevalent in the DLBCL. 30 (49%) patients showed lymph node involvement at surgery, 14 (23%) patients suffered tumor recurrence, and 24 (38.5%) died during the follow-up period. Tumor recurrence occurred primarily in patients who had presented lymph node involvement (9/14, 64.3%). The 5-year survival rate was 66.1% for all patients. Important prognostic factors for overall survival were tumor stage (p < .004) and p53 accumulation (p < .05) in univariate analysis, and tumor stage in multivariate analysis (p < .001). Although p53 accumulation did not reach statistical significance in our small study group, it may be both important in the transformation of low grade MALT lymphoma and an indicator for aggressive behavior in high grade tumors.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11432665     DOI: 10.1078/0344-0338-00051

Source DB:  PubMed          Journal:  Pathol Res Pract        ISSN: 0344-0338            Impact factor:   3.250


  7 in total

1.  Ki-67 proliferative marker in lymph node aspirates of patients with non-Hodgkin's lymphoma.

Authors:  B Mihaljević; R Nedeljkov-Janćić; V Cemerikić-Martinović; D Babić; M Colović
Journal:  Med Oncol       Date:  2006       Impact factor: 3.064

2.  A clinicopathological study of 152 surgically treated primary gastric lymphomas with survival analysis of 109 high grade tumours.

Authors:  R Ranaldi; G Goteri; M G Baccarini; B Mannello; I Bearzi
Journal:  J Clin Pathol       Date:  2002-05       Impact factor: 3.411

3.  A solitary rectal mucosa-associated lymphoid tissue (MALT) lymphoma.

Authors:  A Samee; N Rukin; I Siddiqui; M Halliday; M Farmer
Journal:  BMJ Case Rep       Date:  2010-07-21

4.  Extranodal marginal zone B-cell mucosa-associated lymphoid tissue (MALT) lymphoma of cecum presenting as bright red bleed per rectum--a case report with review of literature.

Authors:  Rohtesh S Mehta; Niyati Modi; Nancy Sapanara; Prashanth Ramachandra; Michael Mikhail
Journal:  J Gastrointest Cancer       Date:  2009-02-19

5.  Unfavourable prognosis of patients with trisomy 18q21 detected by fluorescence in situ hybridisation in t(11;18) negative, surgically resected, gastrointestinal B cell lymphomas.

Authors:  J Krugmann; A Tzankov; S Dirnhofer; F Fend; R Greil; R Siebert; M Erdel
Journal:  J Clin Pathol       Date:  2004-04       Impact factor: 3.411

6.  Gastrointestinal lymphomas in a North American population: clinicopathologic features from one major Central-Midwestern United States tertiary care medical center.

Authors:  Joshua Warrick; Jingqin Luo; Diane Robirds; Julie Branson; John L Frater; Friederike Kreisel; Anjum Hassan; Tudung T Nguyen
Journal:  Diagn Pathol       Date:  2012-06-28       Impact factor: 2.644

7.  Clinicopathologic characteristics and therapeutic outcomes of primary gastrointestinal non-Hodgkin's lymphomas in central Anatolia, in Turkey.

Authors:  Bulent Eser; Bunyamin Kaplan; Ali Unal; Ozlem Canoz; Fevzi Altuntas; H Ismail Sari; Ozlem Er; Metin Ozkan; Can Kucuk; Makbule Arar; Sebnem Gursoy; Mustafa Cetin
Journal:  Yonsei Med J       Date:  2006-02-28       Impact factor: 2.759

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.